SCHEMBL19903448

SCHEMBL19903448

N#Cc1ccccc1-c1ccc2c(c1)c1ccccc1n2-c1cc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(-n2c3ccccc3c3cc(-c4ccccc4C#N)ccc32)c1C#N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.37
AR P10275 5/20 0.37
NR3C1 P04150 1/20 0.36
PGR P06401 2/20 0.35
TRPA1 O75762 1/20 0.34
ALDH1A1 P00352 4/20 0.34
CYP1A2 P05177 4/20 0.34
CYP3A4 P08684 4/20 0.34
HSD17B10 Q99714 3/20 0.34
HPGD P15428 3/20 0.34
MAPT P10636 2/20 0.34
GABRA1 P14867 2/20 0.34
GABRG2 P18507 2/20 0.34
GABRB3 P28472 2/20 0.34
GABRA5 P31644 2/20 0.34
GABRA3 P34903 2/20 0.34
MAPK1 P28482 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19903453 0.97 PTPN5 (0.39) PTPN5ARNR3C1PGRTRPA1
SCHEMBL20617055 0.95 RXRA (0.38) PTPN5ARNR3C1PGRTRPA1
SCHEMBL19903452 0.94 PTPN5 (0.37) PTPN5ARNR3C1PGRTRPA1
SCHEMBL19912402 0.93 AR (0.36) PTPN5ARNR3C1PGRTRPA1
SCHEMBL19918028 0.92 AR (0.48) PTPN5ARNR3C1PGRTRPA1
SCHEMBL20617060 0.92 RXRA (0.39) PTPN5ARNR3C1PGRALDH1A1
SCHEMBL19917601 0.91 PTPN5 (0.37) PTPN5ARNR3C1PGRTRPA1
SCHEMBL19903550 0.90 ICMT (0.37) ALDH1A1MAPTSMN1; SMN2TDP1KDM4E
SCHEMBL19903659 0.90 STS (0.34) ARPGRALDH1A1MAPTSMN1; SMN2
SCHEMBL25658546 0.90 ALOX5AP (0.40) PTPN5ARNR3C1PGRTRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-10-08 US disclosed
EP-3360945-B1 ORGANIC ELECTROLUMINESCENT DEVICE CYNORA GMBH (DE) 2019-04-24 EP disclosed
EP-3287450-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-03-20 EP disclosed
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287450-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, ORC3, AOC3 PTPN5 3579/4885AR 4190/4885NR3C1 3714/4885
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 PTPN5 3658/4885AR 4212/4885NR3C1 3779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.